Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit After Tax
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023
Compare Profit and Loss Results of Fredun Pharma
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
599.00
-251.00
-41.90%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
599.00
-251.00
-41.90%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
1.00
-23.00
-2,300.00%
Raw Materials Consumed
282.00
292.00
-10.00
-3.42%
Power & Fuel Cost
4.00
24.00
-20.00
-83.33%
Employee Cost
12.00
104.00
-92.00
-88.46%
Operating Expenses
10.00
12.00
-2.00
-16.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
33.00
-28.00
-84.85%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
21.00
-20.00
-95.24%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
523.00
-213.00
-40.73%
Operating Profit (PBDIT) excl Other Income
37.00
76.00
-39.00
-51.32%
Other Income
0.00
3.00
-3.00
-100.00%
Operating Profit (PBDIT)
38.00
79.00
-41.00
-51.90%
Interest
13.00
36.00
-23.00
-63.89%
Profit before Depriciation and Tax
25.00
42.00
-17.00
-40.48%
Depreciation
3.00
13.00
-10.00
-76.92%
Profit Before Taxation & Exceptional Items
21.00
29.00
-8.00
-27.59%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
29.00
-8.00
-27.59%
Provision for Tax
5.00
0.00
5.00
0%
Profit After Tax
15.00
30.00
-15.00
-50.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
-138.00
166.00
120.29%
Profit Available for appropriations
44.00
-107.00
151.00
141.12%
Appropriations
44.00
-107.00
151.00
141.12%
Equity Dividend (%)
7%
0%
7.00
Earnings Per Share
33.66
9.32
24.34
261.16%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023
Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023
Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024Figures in Cr
YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023






